Elevation Oncology, Inc. — Form D
Elevation Oncology, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2020-11-18. The offering totals $65.0M, of which $65.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2020-11-18
- Form: D
- Accession: 0001783032-20-000002
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $65.0M
- Amount sold: $65.0M
- Investors: 24
- Date of first sale: 2020-11-10
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-380915
Issuer
- Name: Elevation Oncology, Inc.
- CIK: 0001783032
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 888 SEVENTH AVE, NEW YORK, NY, 10106
- Phone: 212-651-6380
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Timothy Clackson | Director | Waltham, MA |
| Steven Elms | Director | Houston, TX |
| Richard Gaster | Director | Waltham, MA |
| Lori Hu | Director | Houston, TX |
| Shawn Leland | Director | New York, NY |
| Andrew Phillips | Director | New York, NY |
| Colin Walsh | Director | Palo Alto, CA |
| Steven Elms | Executive Officer | Houston, TX |
| Shawn Leland | Executive Officer | New York, NY |
| Steven Elms | Promoter | Houston, TX |
| Shawn Leland | Promoter | New York, NY |
| Michael Caldwell | Director | Boise, ID |
Other filings by this issuer (1)
More